AscellaHealth Releases Q3 2024 Specialty & Rare Pipeline Digest™: FDA-Approved Biosimilars Outpaces Cell and Gene Therapy Amid Complex Regulatory Challenges
October 22, 2024 10:00 ET
|
AscellaHealth, LLC
BERWYN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today released its latest...
AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services
October 17, 2024 06:00 ET
|
AscellaHealth, LLC; CHAPPER healthcare
AscellaHealth Announces Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services
Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®
October 16, 2024 10:00 ET
|
AscellaHealth, LLC
Optime Care Broadens Partnership with Rigel Pharmaceuticals for Expanded Commercial Distribution of TAVALISSE®
U.S. Regulatory Affairs Market Size, Share & Trends Analysis Report 2024-2030 by Services, Category, Indication, Product Stage, Service Provider, Company Size, End-use
July 11, 2024 10:45 ET
|
Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "U.S. Regulatory Affairs Market Size, Share & Trends Analysis Report by Services, Category, Indication, Product Stage, Service Provider, Company...
Key Growth Opportunities in the Oral Solid Dosage Formulation Industry - Fixed Dose Combination Products for Chronic Diseases, Medical Cannabidiol and Phase-appropriate Services for Orphan Drugs
May 27, 2024 04:35 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Oral Solid Dosage Formulation Industry" report has been added to ResearchAndMarkets.com's offering. This analysis...
OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
November 09, 2023 10:23 ET
|
Open Health
London, Nov. 09, 2023 (GLOBE NEWSWIRE) -- London, UK – November 9, 2023 – OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement,...
Accelerate Your Management Skills with The Pharma Mini MBA Training Course, Tailored for Pharmaceutical Professionals (November 8-10, 2023)
November 02, 2023 07:38 ET
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course" conference has been added to ResearchAndMarkets.com's offering. A three-day accelerated management programme to...
Indegene and SynPhNe join hands to bring relief to stroke and TBI victims worldwide
May 16, 2023 07:00 ET
|
Indegene Inc
PRINCETON, N.J. and SINGAPORE, May 16, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, announced today that it is joining hands with SynPhNe, to bring...
Asia-Pacific Pharmaceutical Industry Outlook Report 2023-2027: Top Predictions, Key Trends, Macroeconomic Factors, Revenues, Country-specific Trends, Opportunities
April 20, 2023 09:18 ET
|
Research and Markets
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Asia-Pacific Pharmaceutical Industry Outlook 2023" report has been added to ResearchAndMarkets.com's offering. Asia-Pacific's pharmaceutical market...
MMIT Announces Finalists of the Eighth-Annual Specialty Pharmacy Patient Choice Awards
April 11, 2023 08:00 ET
|
Managed Markets Insight & Technology, LLC
Yardley, PA, April 11, 2023 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner for overcoming barriers to patient access, has announced the...